Evogene Q2 EPS $(0.63) Misses $(0.27) Estimate, Sales $347.000K Beat $325.000K Estimate
Evogene (NASDAQ:EVGN) reported quarterly losses of $(0.63) per share which missed the analyst consensus estimate of $(0.27) by 133.33 percent. This is a 26 percent decrease over losses of $(0.50) per share from the same
Read original at benzinga